News & Updates

Use of a traction device for endoscopic submucosal dissection (ESD) using a scissor-type knife in the proximal colon and for large lesions helps expedite resection in patients with superficial colorectal tumour, a study has shown.

More than a third of women in Singapore have difficulty sleeping, according to a study. Factors such as education level, irritability, vaginal dryness, disability, urinary incontinence, and breast cancer history contribute to poor sleep quality, the magnitude of which varying by ethnicity.

For patients with defunctionalized bladder, bladder cycling prior to renal transplant does little to improve outcomes such as postoperative urological complication, urodynamic criteria, and graft function and survival, according to a study.

Treatment with efgartigimod, a neonatal Fc receptor (FcRn) antagonist, in patients with chronic or persistent immune thrombocytopenia (ITP) resulted in a higher proportion of patients achieving a sustained platelet count response compared with placebo, according to the ADVANCE IV* trial presented at ASH 2022.

Treatment with finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist with a short half-life, results in decreased 24-h, daytime, and night-time systolic blood pressure (SBP), results of a study have shown.

A recent study reports an overall risk of 8.6 percent for hydroxychloroquine (HCQ) retinopathy after 15 years in a large cohort with active surveillance retinopathy screening. Notably, most of these cases are mild, and a higher HCQ dose appears to result in progressively greater risk for incident retinopathy.

A user-friendly medical device can effectively remove the direct thrombin inhibitor (DTI) argatroban from plasma in a rapid and ergonomic manner, as shown in the results of a study presented at ASH 2022.

Treatment with rituximab in patients with pemphigus appears to yield long-term cardiovascular and metabolic protection as compared with conventional immunosuppressants, a study has shown.